This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Charles Marwick

JAMA. 1998;279:1150-1151.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

NEXT YEAR'S influenza vaccine will contain 2 new strains of the A virus.

After a review of the antigenic strains of the virus in circulation, the Vaccines and Related Biological Products Advisory Committee of the Food and Drug Administration (FDA) has recommended that the H3N2 strain in the vaccine for 1998-1999 be represented by A/Sydney/5/97, and the H1N1 strain by A/Beijing/262/95. At a meeting in January, the committee had decided to retain the present B strain, B/Harbin/7/94, in next year's vaccine (JAMA. 1998;279:783).

At that time, the committee deferred a decision on the influenza A strains to be included in the vaccine pending additional information. It provisionally recommended that an A/Sydney/5/95–like component of the H3N2 strain be included because of its widespread circulation. However, the group delayed a final decision to permit the review of more recently isolated A/Sydney–like strains, since it was not clear whether . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pandemic Threat Posed by Avian Influenza A Viruses
Horimoto and Kawaoka
Clin. Microbiol. Rev. 2001;14:129-149.
ABSTRACT | FULL TEXT